中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
Investors
Financials & Filing
2025
2024
2023
2022
2021
2020
2019
2018
2025
2024
2023
2022
2021
2020
2019
2018
Next Day Disclosure Returns - Share Buyback
2024-11-11
Next Day Disclosure Returns - Share Buyback
2024-11-08
Voluntary Announcement - Ascletis Announces Promising Results from a Phase I Study in Australia for First-in-Class Muscle-Preserving Weight Loss Drug Candidate ASC47 for the Treatment of Obesity
2024-11-07
Next Day Disclosure Returns - Share Buyback
2024-11-06
Next Day Disclosure Returns - Share Buyback
2024-11-05
Next Day Disclosure Returns - Share Buyback
2024-11-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
2024-11-01
Next Day Disclosure Returns - Share Buyback
2024-11-01
Next Day Disclosure Returns - Share Buyback
2024-10-31
Next Day Disclosure Returns - Share Buyback
2024-10-30
«
3
4
5
6
»